PHUNG PHAM: Open Payments
NPI 1609436138 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 17 payments from 5 companies in 2025. Trend: 2023 $121 · 2024 $243 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $210 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Cleerly, Inc. | 1 | $16 |
Products named: Ozempic, XHANCE, Wegovy, BREZTRI, GVOKE HYPOPEN, Cleerly Ischemia, AIRSUPRA, Saxenda.
Industry payments across TX — which companies pay providers there.
